Ab&B Bio-Tech (2627) Releases Proxy Form for Second EGM in December 2025

Bulletin Express2025-12-04

Ab&B Bio-Tech (2627) has issued a proxy form for its second extraordinary general meeting of 2025, scheduled for December 23, 2025, at 10 a.m. in Taizhou, Jiangsu, PRC. According to the announcement, shareholders are allowed to appoint proxies to attend this meeting and vote on their behalf. The company emphasizes that any appointed proxy must attend in person and present valid identification.

The upcoming meeting will consider two ordinary resolutions: the proposed appointment of Mr. Li Jianjun as an independent non-executive director and the re-appointment of Deloitte Touche Tohmatsu as auditors for 2025. Shareholders who wish to vote on these matters should complete the proxy form accurately, indicating their instructions regarding each resolution.

The document outlines procedural requirements for submitting proxy forms, including the requirement for shareholders to lodge completed forms with the company's H share registrar, Tricor Investor Services Limited, at least 24 hours before the meeting time. The notice also specifies that if shareholders attend in person after submitting a proxy form, their proxy instructions will be deemed revoked. Additional details, such as joint shareholding arrangements and identity verification, can be found in the official circular accompanying the proxy form.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1168334587?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-04 22:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168334587","market":"us","top_or_hot":-1,"title":"Ab&B Bio-Tech (2627) Releases Proxy Form for Second EGM in December 2025","media":"Bulletin Express","content":"<p>Ab&B Bio-Tech (2627) has issued a proxy form for its second extraordinary general meeting of 2025, scheduled for December 23, 2025, at 10 a.m. in Taizhou, Jiangsu, PRC. According to the announcement, shareholders are allowed to appoint proxies to attend this meeting and vote on their behalf. The company emphasizes that any appointed proxy must attend in person and present valid identification.</p>\n<p>The upcoming meeting will consider two ordinary resolutions: the proposed appointment of Mr. Li Jianjun as an independent non-executive director and the re-appointment of Deloitte Touche Tohmatsu as auditors for 2025. Shareholders who wish to vote on these matters should complete the proxy form accurately, indicating their instructions regarding each resolution.</p>\n<p>The document outlines procedural requirements for submitting proxy forms, including the requirement for shareholders to lodge completed forms with the company's H share registrar, Tricor Investor Services Limited, at least 24 hours before the meeting time. The notice also specifies that if shareholders attend in person after submitting a proxy form, their proxy instructions will be deemed revoked. Additional details, such as joint shareholding arrangements and identity verification, can be found in the official circular accompanying the proxy form.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ab&B Bio-Tech (2627) Releases Proxy Form for Second EGM in December 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAb&B Bio-Tech (2627) Releases Proxy Form for Second EGM in December 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-04 22:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ab&B Bio-Tech (2627) has issued a proxy form for its second extraordinary general meeting of 2025, scheduled for December 23, 2025, at 10 a.m. in Taizhou, Jiangsu, PRC. According to the announcement, shareholders are allowed to appoint proxies to attend this meeting and vote on their behalf. The company emphasizes that any appointed proxy must attend in person and present valid identification.</p>\n<p>The upcoming meeting will consider two ordinary resolutions: the proposed appointment of Mr. Li Jianjun as an independent non-executive director and the re-appointment of Deloitte Touche Tohmatsu as auditors for 2025. Shareholders who wish to vote on these matters should complete the proxy form accurately, indicating their instructions regarding each resolution.</p>\n<p>The document outlines procedural requirements for submitting proxy forms, including the requirement for shareholders to lodge completed forms with the company's H share registrar, Tricor Investor Services Limited, at least 24 hours before the meeting time. The notice also specifies that if shareholders attend in person after submitting a proxy form, their proxy instructions will be deemed revoked. Additional details, such as joint shareholding arrangements and identity verification, can be found in the official circular accompanying the proxy form.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02627","symbol_name":"中慧生物-B","start_time":0,"source_url":"","article_id":"1168334587","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168334587","pubTimestamp":1764859465,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Ab&B Bio-Tech (2627) has issued a proxy form for its second extraordinary general meeting of 2025, scheduled for December 23, 2025, at 10 a.m. in Taizhou, Jiangsu, PRC. According to the announcement,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02627":"中慧生物-B"},"translate_title":"Ab&B Bio-Tech(2627)发布2025年12月第二次临时股东大会委托书","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02627":1},"content_text":"Ab&B Bio-Tech (2627) has issued a proxy form for its second extraordinary general meeting of 2025, scheduled for December 23, 2025, at 10 a.m. in Taizhou, Jiangsu, PRC. According to the announcement, shareholders are allowed to appoint proxies to attend this meeting and vote on their behalf. The company emphasizes that any appointed proxy must attend in person and present valid identification.\nThe upcoming meeting will consider two ordinary resolutions: the proposed appointment of Mr. Li Jianjun as an independent non-executive director and the re-appointment of Deloitte Touche Tohmatsu as auditors for 2025. Shareholders who wish to vote on these matters should complete the proxy form accurately, indicating their instructions regarding each resolution.\nThe document outlines procedural requirements for submitting proxy forms, including the requirement for shareholders to lodge completed forms with the company's H share registrar, Tricor Investor Services Limited, at least 24 hours before the meeting time. The notice also specifies that if shareholders attend in person after submitting a proxy form, their proxy instructions will be deemed revoked. Additional details, such as joint shareholding arrangements and identity verification, can be found in the official circular accompanying the proxy form.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1168334587","isCrawlerRequest":true}